
Novel anticancer compound [trifluoromethyl-substituted pyrazole N-nucleoside] inhibits FLT3 activity to induce differentiation in acute myeloid leukemia cells
Keywords: Heterocyclic compound; Trifluoromethyl-substituted pyrazole N-nucleosides; Anticancer; Acute myeloid leukemia (AML); Cell differentiation; FLT3; G-11; [1-(2â³,3â³,4”,6â³-Tetra-O-acetyl-β-D-glucopyranosyl)-4-(3â²-trifluoromethylphenyl hydrazono)-3-t